克西拉会加剧芬太尼诱导的呼吸抑制和胸
Catherine Demery1, Sierra C Moore1, Erica S Levitt2
1Edward F. Domino Research Center, Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan.
概括
克西拉恶化了芬太尼的情况.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 致命的阿片类药物过量服用,主要涉及芬太尼,在美国激增.
- 非法芬太尼越来越多地与兽医麻醉剂西拉混杂.
- 克西拉增强了芬太尼的致命性,但机制尚不清楚.
研究的目的:
- 为了研究芬太尼和西拉单独或组合的呼吸和心血管作用.
- 阐明克西拉加剧芬太尼毒性的机制.
主要方法:
- 整体肺缩图测量呼吸速率和呼吸模式.
- 脉冲氧度测试以评估血液中的氧和和心率.
- 在雄性和雌性CD-1小鼠中进行的实验.
主要成果:
- 克西拉增加了过期时间,比芬太尼更降低了呼吸速率.
- 芬太尼抑制了灵感;西拉加剧了这种效应.
- 芬太尼降低了血液中的氧和度; 克西拉没有加剧芬太尼诱导的缺氧.
- 克西拉在较高剂量下比芬太尼更能降低心率.
- 血中氧度降低与严重的呼吸暂停相关,而不是整体呼吸速率.
结论:
- 克西拉在小鼠中显著加剧了芬太尼诱导的呼吸抑制.
- 芬太尼和西拉的组合会增加过量服用的风险.
- 严重的呼吸暂停,而不是减少呼吸速率,与芬太尼诱导的缺氧有关.
相关概念视频
Parenteral Anesthetics: Overview
211
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
211
Skeletal Muscle Relaxants: Adverse Effects
485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
485
Sedatives and Hypnotics Drugs: Barbiturates
510
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
510
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
554
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
554
CNS Depressants: Barbiturates and Benzodiazepines
484
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
484
Opioid Analgesics: Synthetic and Semisynthetic Opioids
453
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
453


